Working Paper | HBS Working Paper Series | 2020

Tamoxifen: Case Histories of Significant Medical Advances

by Amar Bhidé, Srikant Datar and Katherine Stebbins

Abstract

Our case history describes the development of tamoxifen, considered a “gold standard” treatment for millions of breast cancer patients. Specifically, we describe breast cancer treatments prior to tamoxifen’s development; the initial development of tamoxifen from 1960 to 1973; tamoxifen’s adoption as an adjuvant breast cancer treatment between 1973 and 1985; and the extension of tamoxifen’s use to include preventative treatment, between 1986 and 2002.

Keywords: Health Care and Treatment; Technological Innovation; Innovation and Invention; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Governing Rules, Regulations, and Reforms;

Language: English Format: Print 21 pages SSRN Read Now

Citation:

Bhidé, Amar, Srikant Datar, and Katherine Stebbins. "Tamoxifen: Case Histories of Significant Medical Advances." Harvard Business School Working Paper, No. 20-134, July 2020. (Revised August 2020.)

About the Authors

Photo
Amar Bhide
Visiting Professor of Business Administration
General Management

View Profile »
View Publications »

 
Photo
Srikant M. Datar
Arthur Lowes Dickinson Professor of Business Administration
Senior Associate Dean for University Affairs
Accounting and Management

View Profile »
View Publications »

 
Campus Map
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→ Map & Directions
Copyright © President & Fellows of Harvard College